Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

Implement Prescription Drug Affordability Programs

Concerning the implementation of certain affordable prescription drug programs, and, in connection therewith, making an appropriation.
2024 Regular Session
Health Care & Health Insurance
Bill Summary

The bill makes it a deceptive trade practice under the "Colorado Consumer Protection Act" for a manufacturer to fail to comply with:

  • The manufacturer requirements under the insulin affordability program; and
  • The manufacturer requirements for the emergency supply of prescription insulin.

The bill authorizes the attorney general to enforce:

  • The insulin affordability program;
  • The requirements for the emergency supply of prescription insulin; and
  • The epinephrine auto-injector affordability program (epinephrine program).

For the insulin affordability program, the state board of pharmacy (board) shall develop an application form for the insulin affordability program, make the application form available on the board's website, provide the application form to pharmacies and health-care providers and others, and promote the availability of the program to Coloradans.

The bill also increases the amount of a fine for a manufacturer's failure to comply with the requirements of the insulin affordability program or with the requirements for the emergency supply of prescription insulin, and or for failure to comply with the epinephrine program, to the amount and frequency of the fine that is permitted under the "Colorado Consumer Protection Act". For the epinephrine program, the bill requires all manufacturers subject to the epinephrine program to participate in the epinephrine program. The state board of pharmacy to shall develop a program application form and make the form available to individuals, pharmacies, health-care providers, and health facilities through the epinephrine program's website, with each manufacturer required to link to the epinephrine program on the manufacturer's website. The board shall also provide flyers to be distributed information to pharmacies about the epinephrine program that include includes a quick response (QR) code to allow individuals to access and complete the epinephrine program's application online, The completed, printed application will include a billing code or other method including how to submit the application, and information necessary for the a dispensing pharmacy to be reimbursed successfully submit an electronic claim for reimbursement for the cost of the to dispense an epinephrine auto-injector to an individual, above any required cost sharing by the individual.

(Note: Italicized words indicate new material added to the original summary; dashes through words indicate deletions from the original summary.)

(Note: This summary applies to the reengrossed version of this bill as introduced in the second house.)


Became Law


Bill Text

The effective date for bills enacted without a safety clause is August 7, 2024, if the General Assembly adjourns sine die on May 8, 2024, unless otherwise specified. Details